This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, A. A.
Right arrow Articles by Riley, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, A. A.
Right arrow Articles by Riley, P. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2004, p. 9835-9847, Vol. 24, No. 22
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.22.9835-9847.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Differential Regulation of Hand1 Homodimer and Hand1-E12 Heterodimer Activity by the Cofactor FHL2

Alison A. Hill{dagger} and Paul R. Riley*

Molecular Medicine Unit, Institute of Child Health, London, United Kingdom

Received 3 March 2004/ Returned for modification 28 April 2004/ Accepted 19 August 2004

The basic helix-loop-helix (bHLH) factor Hand1 plays an essential role in cardiac morphogenesis, and yet its precise function remains unknown. Protein-protein interactions involving Hand1 provide a means of determining how Hand1-induced gene expression in the developing heart might be regulated. Hand1 is known to form either heterodimers with near-ubiquitous E-factors and other lineage-restricted class B bHLH proteins or homodimers with itself in vitro. To date, there have been no reported Hand1 protein interactions involving non-bHLH proteins. Heterodimer-versus-homodimer choice is mediated by the phosphorylation status of Hand1; however, little is known about the in vivo function of these dimers or, importantly, how they are regulated. In an effort to understand how Hand1 activity in the heart might be regulated postdimerization, we have investigated tertiary Hand1-protein interactions with non-bHLH factors. We describe a novel interaction of Hand1 with the LIM domain protein FHL2, a known transcriptional coactivator and corepressor expressed in the developing cardiovascular system. FHL2 interacts with Hand1 via the bHLH domain and is able to repress Hand1/E12 heterodimer-induced transcription but has no effect on Hand1/Hand1 homodimer activity. This effect of FHL2 is not mediated either at the level of dimerization or via an effect of Hand1/E12 DNA binding. In summary, our data describe a novel differential regulation of Hand1 heterodimers versus homodimers by association of the cofactor FHL2 and provide insight into the potential for a tertiary level of control of Hand1 activity in the developing heart.

* Corresponding author. Mailing address: Molecular Medicine Unit, Institute of Child Health, 30 Guilford St., London WC1N 1EH, United Kingdom. Phone: 44 (0) 20 7905 2345. Fax: 44 (0) 20 7404 6191. E-mail: p.riley{at}ich.ucl.ac.uk.

{dagger} Present address: Immunobiology Unit, Institute of Child Health, London WC1N 1EH, United Kingdom.

Molecular and Cellular Biology, November 2004, p. 9835-9847, Vol. 24, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.22.9835-9847.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Han, W., Wu, Z., Zhao, Y., Meng, Y., Si, Y., Yang, J., Fu, X., Yu, L. (2009). FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells. Nucleic Acids Res 0: gkp332v1-gkp332 [Abstract] [Full Text]  
  • Funato, N., Chapman, S. L., McKee, M. D., Funato, H., Morris, J. A., Shelton, J. M., Richardson, J. A., Yanagisawa, H. (2009). Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2. Development 136: 615-625 [Abstract] [Full Text]  
  • Risebro, C. A., Searles, R. G., Melville, A. A. D., Ehler, E., Jina, N., Shah, S., Pallas, J., Hubank, M., Dillard, M., Harvey, N. L., Schwartz, R. J., Chien, K. R., Oliver, G., Riley, P. R. (2009). Prox1 maintains muscle structure and growth in the developing heart. Development 136: 495-505 [Abstract] [Full Text]  
  • Reamon-Buettner, S. M., Ciribilli, Y., Inga, A., Borlak, J. (2008). A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Hum Mol Genet 17: 1397-1405 [Abstract] [Full Text]  
  • Cottle, D. L., McGrath, M. J., Cowling, B. S., Coghill, I. D., Brown, S., Mitchell, C. A. (2007). FHL3 binds MyoD and negatively regulates myotube formation. J. Cell Sci. 120: 1423-1435 [Abstract] [Full Text]  
  • Risebro, C. A., Smart, N., Dupays, L., Breckenridge, R., Mohun, T. J., Riley, P. R. (2006). Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart. Development 133: 4595-4606 [Abstract] [Full Text]  
  • Vogel, J. L., Kristie, T. M. (2006). Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors. Proc. Natl. Acad. Sci. USA 103: 6817-6822 [Abstract] [Full Text]  
  • Morin, S., Pozzulo, G., Robitaille, L., Cross, J., Nemer, M. (2005). MEF2-dependent Recruitment of the HAND1 Transcription Factor Results in Synergistic Activation of Target Promoters. J. Biol. Chem. 280: 32272-32278 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»